30 Immunotherapy in advanced NSCLC—from the ‘tsunami’ of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT)

Although lung cancer remains the leading cause of death from cancer worldwide, the advent of immunotherapy is changing the survival of patients affected by non-small cell lung cancer (NSCLC). A multitude of clinical trials are evaluating different immune checkpoints inhibitors in this new field of t...

Descripción completa

Detalles Bibliográficos
Autores principales: de Marinis, Filippo, Ciardiello, Fortunato, Baas, Paul, Crinò, Lucio, Giaccone, Giuseppe, Grossi, Francesco, Hellmann, Matthew D, Mok, Tony S K, Lena, Hervè, Paz-Ares, Luis, Rodriguez-Abreu, Delvys, Von Pavel, Joachim, Gridelli, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012561/
https://www.ncbi.nlm.nih.gov/pubmed/29942662
http://dx.doi.org/10.1136/esmoopen-2017-000298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012561/
https://www.ncbi.nlm.nih.gov/pubmed/29942662
http://dx.doi.org/10.1136/esmoopen-2017-000298

Ejemplares similares